Axel S. Merseburger· @amerseburger · X·· 2 天前评分90
正文 · 机器翻译
KEYNOTE-866 未显示 EFS，也未显示 OS。Jens Bedke 教授的精彩演讲 👏🏼 #ESMO26 @OncoAlert @Uromigos @urotoday @Uroweb @DGUrologie @high5md
928 浏览 · 19 赞 · 14 转发 · 1 回复
会议摘要
4735O按 Proffered paper 1: Genitourinary tumour, renal and urothelial 对上
Perioperative pembrolizumab (pembro) or placebo (pbo) + neoadjuvant cisplatin (cis) and gemcitabine (gem) in participants (pts) with muscle-invasive bladder cancer (MIBC): the double-blind, phase 3 KEYNOTE-866 study
https://esmocongress.esmo.org帖内回复
- Stefania Colasanti@Stefani19753108
@amerseburger @OncoAlert @Uromigos @urotoday @Uroweb @DGUrologie @high5md @cnsternberg 👏👏👏 Prof Jens Bedke 👏👏👏! Great job in Madrid @cnsternberg @amerseburger @OncoAlert @Uromigos @urotoday @Uroweb @DGUrologie @high5md 🙌🙌🙌🙌
来源：Axel S. Merseburger · x.com